Anti-inflammatory, immunomodulatory and antiproliferative agent. Inhibits p56lck
and syk protein tyrosine kinases and inhibits TNF-induced NF-κ
B activation and gene expression. Synthesis results from conversion of resveratrol
(Cat. No. 1418) by cytochrome P450 1B1.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Piceatannol (3,4,3',5'-tetrahydroxy-trans-stilbene) is a naturally occurring protein-tyrosine kinase inhibitor.
Geahlen and McLaughlin
The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1.
Potter et al.
Inhibition of mast cell FceR1-mediated signalling and effector function by the syk-selective inhibitor, piceatannol.
Oliver et al.
Piceatannol inhibits TNF-induced NF-kB activation and NF-kB-mediated gene expression through suppression of IkBa kinase and p65 phosphorylation.
Ashikawa et al.
The citations listed below are publications that use Tocris products. Selected citations for Piceatannol include:
Showing Results 1 - 5 of 5